Evelo Biosciences, Inc. (EVLO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Jul 31, 2025, 1:16 PM EDT
Evelo Biosciences Market Cap
Evelo Biosciences has a market cap or net worth of $9.49 thousand as of August 1, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
9.49K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 9, 2018, Evelo Biosciences's market cap has decreased from 517.90M to 9.49K, a decrease of -100.00%. That is a compound annual growth rate of -77.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 9.49K | - |
Dec 30, 2024 | 9.49K | -99.19% |
Dec 29, 2023 | 1.17M | -99.34% |
Dec 30, 2022 | 176.48M | -45.62% |
Dec 31, 2021 | 324.50M | -41.89% |
Dec 31, 2020 | 558.43M | 328.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
May 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.80B |
Veradigm | 832.17M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 546.09M |
Glass House Brands | 396.28M |
CytoDyn | 371.08M |
Nika Pharmaceuticals | 366.89M |
Northwest Biotherapeutics | 361.28M |